You can buy or sell SLNO and other stocks, options, ETFs, and crypto commission-free!
Soleno Therapeutics, Inc. Common Stock, also called Soleno Therapeutics, is a healthcare company, focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. Read More It markets CoSense End-Tidal Carbon Monoxide monitor, which measures ETCO and is used by hospitals to detect hemolysis in newborns. The company was founded on August 25, 1999 and is headquartered in Redwood City, CA.
Redwood City, California
52 Week High
52 Week Low
Simply Wall St17h
Did Changing Sentiment Drive Soleno Therapeutics’s (NASDAQ:SLNO) Share Price Down A Worrying 68%?
Soleno Therapeutics, Inc. (NASDAQ:SLNO) shareholders are doubtless heartened to see the share price bounce 52% in just one week. But that doesn’t change the fact that the returns over the last three years have been disappointing. In that time, the share price dropped 68%. So it’s good to see it climbing back up. The rise has some hopeful, but turnarounds are often precarious. View our latest analysis for Soleno Therapeutics Soleno Therapeutics didn’t have any revenue in the last year, so it’s fair to say ...
Soleno Therapeutics News: Why SLNO Stock Is Skyrocketing Today Soleno Therapeutics News: Why SLNO Stock Is Skyrocketing Today
Soleno Therapeutics (NASDAQ: SLNO ) had a Friday to remember as the biopharmaceutical company made some headway in a successful clinical trial of a treatment for a genetic disorder.
$0.02 per share